Ares Capital Research and Development Expenses 2010-2025 | ARCC

Ares Capital annual/quarterly research and development expenses history and growth rate from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Ares Capital research and development expenses for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Ares Capital research and development expenses for the twelve months ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Ares Capital annual research and development expenses for 2024 were $0B, a 0% decline from 2023.
  • Ares Capital annual research and development expenses for 2023 were $0B, a 0% decline from 2022.
  • Ares Capital annual research and development expenses for 2022 were $0B, a 0% decline from 2021.
Ares Capital Annual Research and Development Expenses
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Ares Capital Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Finance FIN-SBIC&COMMRL $14.344B $2.990B
Ares Capital Corporation is a specialty finance company, which primarily invests in U.S. middle-market companies. The company offers customized financing solutions, ranging from senior-debt instruments to equity capital, with a focus on senior secured debt. Other major investment areas were commercial & professional services, diversified financials, and insurance services. Ares Capital is structured as a non-diversified closed-end management investment company, regulated as a business development company under the Investment Company Act of 1940. It is treated as a regulated investment company ('RIC') for income-tax purposes. To maintain its RIC status, Ares Capital must distribute the majority of its investment income.
Stock Name Country Market Cap PE Ratio
Blackstone Secured Lending Fund (BXSL) US $6.755B 8.45
FS KKR Capital (FSK) US $5.596B 6.94
Main Street Capital (MAIN) US $4.767B 13.19
Golub Capital BDC (GBDC) US $3.805B 7.75
Hercules Capital (HTGC) US $3.096B 9.01
Sixth Street Specialty Lending (TSLX) US $1.961B 8.92
Morgan Stanley Direct Lending Fund (MSDL) US $1.707B 7.80
Goldman Sachs BDC (GSBD) US $1.247B 4.92
Kayne Anderson BDC (KBDC) US $1.139B 0.00
New Mountain Finance (NMFC) US $1.075B 7.22
Bain Capital Specialty Finance (BCSF) US $1.000B 7.38
BARINGS BDC, INC (BBDC) US $0.922B 7.00
Amalgamated Financial (AMAL) US $0.905B 8.33
Trinity Capital (TRIN) US $0.900B 6.79
Nuveen Churchill Direct Lending (NCDL) US $0.817B 7.03
Carlyle Secured Lending (CGBD) US $0.749B 7.31
Fidus Investment (FDUS) US $0.662B 8.26
Crescent Capital BDC (CCAP) US $0.593B 6.64
BLACKROCK TCP CAPITAL CORP (TCPC) US $0.574B 4.19
Gladstone Capital (GLAD) US $0.567B 13.96
CION Investment (CION) US $0.527B 5.58
Gladstone Investment (GAIN) US $0.515B 14.73
Palmer Square Capital BDC (PSBD) US $0.429B 6.78
PennantPark Investment (PNNT) US $0.426B 7.42
Stellus Capital Investment (SCM) US $0.369B 7.60
Saratoga Investment Corp (SAR) US $0.357B 5.90
Runway Growth Finance (RWAY) US $0.344B 5.65
Horizon Technology Finance (HRZN) US $0.298B 6.05
TriplePoint Venture Growth BDC (TPVG) US $0.244B 4.31
Chicago Atlantic BDC (LIEN) US $0.237B 17.63
WhiteHorse Finance (WHF) US $0.223B 5.99
Medallion Financial (MFIN) US $0.211B 5.68
Oxford Square Capital (OXSQ) US $0.176B 6.15
PhenixFIN (PFX) US $0.100B 21.44
Advanced Medical Isotope (RDGL) US $0.068B 0.00
Rand Capital (RAND) US $0.056B 10.88
Logan Ridge Finance (LRFC) US $0.048B 11.53
Investcorp Credit Management BDC (ICMB) US $0.042B 6.42
SLR Investment (SLRC) US $0.000B 8.79
OFS Capital (OFS) US $0.000B 8.04